Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study. 1987

C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
Hôpitaux de Paris, France.

UI MeSH Term Description Entries
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D004756 Enterobacteriaceae Infections Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
August 1988, Israel journal of medical sciences,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
June 1975, The Japanese journal of antibiotics,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
April 1987, The Pediatric infectious disease journal,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
September 1984, The Journal of antimicrobial chemotherapy,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
April 1990, Presse medicale (Paris, France : 1983),
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
January 1989, Chemotherapy,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
December 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
January 1979, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
January 1999, Gaceta medica de Mexico,
C Carbon, and C Auboyer, and B Becq-Giraudon, and P Bertrand, and H Gallais, and Y Mouton, and J P Motin, and F Vachon, and J M Wasmer, and A Buré
October 1988, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!